GREENLAND MINES LTD Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent
GREENLAND MINES LTD (GRML) reported Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent of 33.90% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-17.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent · last filed 2024-04-17
- GREENLAND MINES LTD effective income tax rate reconciliation,other reconciling items, percent for fiscal 2023 was 33.90%, a 63.77% increase from fiscal 2022.
- GREENLAND MINES LTD effective income tax rate reconciliation,other reconciling items, percent for fiscal 2022 was 20.70%.
| Period end | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent 12 month |
|---|---|
| 2023-12-31 | 33.90% 10-K · filed 2024-04-17 |
| 2022-12-31 | 20.70% 10-K · filed 2024-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |